On 20 September 2022, the Ministry of Health in Uganda, together with the World Health Organization - Regional Office for Africa (WHO AFRO), confirmed an outbreak of Ebola virus disease (EVD) due to Sudan ebolavirus in Mubende District, Uganda.
Depending on the level of evidence provided and the methodology used, this advice is typically conveyed through a Guidance, a Systematic review or an Expert opinion.
Recent epidemics of Ebola virus disease in Africa have increased the potential risk of Ebola virus transmission via donated blood and blood components, cells, tissues and organs (substances of human origin; SoHO), not only locally and regionally in Africa, but also in non-endemic unaffected areas such as Europe due to population movements.
In a two-day meeting organised by ECDC and UNAIDS, representatives of 22 European countries discussed how to improve the delivery of HIV pre-exposure prophylaxis (PrEP) across Europe. The meeting brought together country delegates, PrEP users and community HIV advocates to seek ways to strengthen the provision and monitoring of PrEP.
The conference addressed long-term effectiveness HIV of drugs, co-infections with tuberculosis or viral hepatitis and other co-morbidities, and most inequitable access to care across Europe
Treatment enables people with HIV infection to live a long, healthy and productive life. It also reduces their viral load significantly and this has been shown to be important in preventing onward transmission of HIV.